Frontiers in Oncology

Original Research

Accepted on 23 Apr 2025

A Trispecific Antibody targeting EGFR/cMET/VEGF Demonstrates Multiple Mechanisms of Action to inhibit Wild-Type and Mutant NSCLC Animal Models

in Cancer Molecular Targets and Therapeutics

Mark L Chiu
Karen Jin
Ping Sun
Peng Chen
Yuqiang Xu
Guangmao Mu
Zhengxia Zha
Simin Wu
Meixia Fu
Hao Jiang

Frontiers in Oncology

doi 10.3389/fonc.2025.1533059

Original Research

Accepted on 23 Apr 2025

Novel Ultrasound Features and Diagnostic Clues of Gastric-type Endocervical Adenocarcinoma: A Case Series

in Cancer Imaging and Image-directed Interventions

Liwen Yang
Yangyang Wang
Jian Cai
Ying Xiong
Juan Li
Qi Zhou
Nan Ye
Hua Lai
Tianjiao Liu
Liuying Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1572438

Original Research

Accepted on 23 Apr 2025

Iodine-131 Induces Ferroptosis and Synergizes with Sulfasalazine in Differentiated Thyroid Cancer Cells via Suppressing SLC7A11

in Pharmacology of Anti-Cancer Drugs

Li Ling
JH Zhang
Xiao Zhang
Peiqi Wang
Mingjun Ma
Bingling Yin

Frontiers in Oncology

doi 10.3389/fonc.2025.1580828

Systematic Review

Accepted on 23 Apr 2025

Research trends and hotspots of circulating tumor DNA in colorectal cancer: A bibliometric study

in Gastrointestinal Cancers: Colorectal Cancer

Lele Zhang
Yuzhe Zhang
Lei Chen
Xu Wang
Yulian Liu
Yishan Huang
Yu Song
Ye Zhang
Jiandong Tai

Frontiers in Oncology

doi 10.3389/fonc.2025.1492880

Case Report

Accepted on 23 Apr 2025

Stevens-Johnson Syndrome Induced by Sintilimab: A Case Report and Literature Review

in Thoracic Oncology

Huan Kuang
Dongbei Huang
Chuxiang Hu
Liping Gong
Ziyu Yu
Xunjin Zhu
Hongrong Lan
Gang Huang

Frontiers in Oncology

doi 10.3389/fonc.2025.1568316

Correction

Accepted on 23 Apr 2025

Analysis of the differencesbetween HPV-independentand HPV-related cervicaladenocarcinoma

in Gynecological Oncology

Jing He
Gulixian TuLuWengJiang
Lin Zeng

Frontiers in Oncology

doi 10.3389/fonc.2025.1613729

Original Research

Accepted on 23 Apr 2025

MYB Proto-Oncogene Like 2 Identified as a Biomarker for Uterine Corpus Endometrial Carcinoma: evidence from Bioinformatics and Clinical Validation

in Cancer Immunity and Immunotherapy

Jiaoyun Lu
Furong Luo

Frontiers in Oncology

doi 10.3389/fonc.2025.1595485

Original Research

Accepted on 23 Apr 2025

Integrated single-cell and transcriptome sequencing data reveal the value of IL1RAP in gastric cancer microenvironment and prognosis

in Cancer Immunity and Immunotherapy

Weifeng Yang
Xiaohua Wu
Jian Wang
Wenquan Ou
Xing Huang

Frontiers in Oncology

doi 10.3389/fonc.2025.1584619

120 views

Original Research

Accepted on 23 Apr 2025

Personalized Prediction of Breast Cancer Candidates for Anti-HER2 Therapy Using 18 F-FDG PET/CT Parameters and Machine Learning: A Dual-Center Study

in Breast Cancer

Zhenguo Sun
Jianxiong Gao
Yu Wenji
Xiaoshuai Yuan
Peng Du
Peng Chen
Yuetao Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1590769

Original Research

Published on 23 Apr 2025

Feasibility study for proton dose calculation of esophageal squamous cell carcinoma based on stopping power ratio directly derived from dual energy CT

in Cancer Imaging and Image-directed Interventions

Miaomiao Li
Yongbin Cui
Xinjun Lin
Yuanyuan Yan
Qianyu Liu
Mingming Nie
Wenzhen Gong Ye
Yong Huang
Jinhu Chen
Yong Yin

Frontiers in Oncology

doi 10.3389/fonc.2025.1591139

104 views

Correction

Published on 23 Apr 2025

Corrigendum: Inhibition of ATM or ATR in combination with hypo-fractionated radiotherapy leads to a different immunophenotype on transcript and protein level in HNSCC

in Molecular and Cellular Oncology

Julia Meidenbauer
Matthias Wachter
Sebastian R. Schulz
Nada Mostafa
Lilli Zülch
Benjamin Frey
Rainer Fietkau
Udo S. Gaipl
Tina Jost

Frontiers in Oncology

doi 10.3389/fonc.2025.1607882

161 views

Case Report

Accepted on 22 Apr 2025

Rare comorbidity of colon cancer, hepatic malignant mesothelioma, and abdominal Ewing's sarcoma:A case report

in Surgical Oncology

Yanru Li
Lukang Teng
Shupeng Wang
Xudong Wu
Tianchen Huang

Frontiers in Oncology

doi 10.3389/fonc.2025.1558347

142 views

Original Research

Accepted on 22 Apr 2025

Real-world treatment patterns and outcomes among patients initiating SEQuential Regorafenib and Trifluridine/Tipiracil+/-bevacizumab in patients with metastatic colorectal cancer in a US community setting (SEQRT2)

in Gastrointestinal Cancers: Colorectal Cancer

Tanios Bekaii-Saab
Ila Sruti
Junxin Shi
Wei Dai
Gregory Patton
Sreevalsa Appukkuttan
Brian Hocum
Arvind Katta
Svetlana Babajanyan
David Cosgrove

Frontiers in Oncology

doi 10.3389/fonc.2025.1591245

201 views

Case Report

Accepted on 22 Apr 2025

Cord blood therapy for pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: case series and review

in Hematologic Malignancies

Zhen Li
Sujing Zhuang
Gui Ruirui
Binglei Zhang
Wenli Zhang
Juan Wang
Yingling Zu
Fei Yang
Xiangke Xin
Yanyan Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1585088

108 views

Original Research

Accepted on 22 Apr 2025

Efficacy and safety of blinatumomab in Chinese patients with relapsed/refractory B-cell acute lymphoblastic leukemia: a single-center retrospective study

in Hematologic Malignancies

Yan Wang
Chun Chang
Zhen Wang
Jie Zhao
Jingbo Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1587185

100 views

Original Research

Accepted on 22 Apr 2025

Efficacy and Safety of Pegylated Interferon in the Treatment of JAK2 V617F -Positive Polycythemia Vera with a Dose De-escalation Strategy: A Single-Center Retrospective Study

in Hematologic Malignancies

Long Chang
Wen-Xin Li
Hao Cai
Jian Li
Minghui Duan

Frontiers in Oncology

doi 10.3389/fonc.2025.1586839

102 views